trial · primary record
Placebo
SBP - Spontaneous Bacterial Peritonitis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2027-06-01 |
| Primary endpoint | Percentage change in ascitic-fluid polymorphonuclear (PMN) count from baseline to 48 hours after initiation of treatment |
| Registry ID | NCT07803952 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:51.483Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07803952
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound